|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
EBOOKCENTRAL_ocn843754088 |
003 |
OCoLC |
005 |
20240329122006.0 |
006 |
m eo d |
007 |
cr cn||||m|||a |
008 |
130520s2013 enka ob 001 0 eng d |
040 |
|
|
|a J2I
|b eng
|e pn
|c J2I
|d J2I
|d YDXCP
|d EBLCP
|d OCLCQ
|d MERUC
|d OCLCF
|d OCLCO
|d UKMGB
|d OCLCO
|d OCLCQ
|d OCLCA
|d OCLCQ
|d MM9
|d OCLCO
|d OCLCQ
|d CASUM
|d OCLCO
|d OCLCL
|d OCLCQ
|
016 |
7 |
|
|a 017854354
|2 Uk
|
019 |
|
|
|a 854971660
|
020 |
|
|
|a 9781780842707
|q (eISBN)
|
020 |
|
|
|a 1780842708
|q (eISBN)
|
020 |
|
|
|a 9781780842714
|q (ePub)
|
020 |
|
|
|a 1780842716
|q (ePub)
|
020 |
|
|
|z 9781780842721
|q (print)
|
024 |
7 |
|
|a 10.2217/9781780842707
|2 doi
|
029 |
1 |
|
|a UKMGB
|b 017854354
|
035 |
|
|
|a (OCoLC)843754088
|z (OCoLC)854971660
|
037 |
|
|
|a 10.2217/9781780842707
|b Future Science
|
050 |
|
4 |
|a RC848.H425
|b E648 2013eb
|
060 |
|
4 |
|a WC 536
|b E648 2013eb
|
082 |
0 |
4 |
|a 616.3/62306
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Emerging therapeutic options for hepatitis C /
|c editors, Masao Omata, Tatsuo Kanda.
|
260 |
|
|
|a London, England :
|b Future Medicine Ltd (Unitec House, 2 Albert Place, London N3 1QB, UK),
|c ©2013.
|
300 |
|
|
|a 1 online resource (113 pages) :
|b color illustrations, digital file
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a Hepatitis C virus infection : from discovery to eradication / Masao Omata & Tatsuo Kanda -- Interferons in clinical trials / Tatsuo Kanda, Osamu Yokosuka & Masao Omata -- Protease inhibitors / Marion Corouge, Philippe Sogni & Stanislas Pol -- NS5A inhibitor : daclatasvir / Kazuaki Chayama & C. Nelson Hayes -- Toll-like receptor agonists for nonresponders to HCV treatment : hope versus promise? / Valérie Martel-Laferrière & Douglas Dieterich -- Treatment options in HIV-HCV-coinfected patients / Philippe Sogni, Marion Corouge & Stanislas Pol -- Treatment options for dual HCV/HBV coinfection / Chun-Jen Liu & Jia-Horng Kao -- HCV treatment in patients with metabolic syndrome / Luigi E. Adinolfi, Rosa Zampino, Luciano Restivo, Amedeo Lonardo & Paola Loria -- Future directions in hepatitis C therapy / Stevan A. Gonzalez -- Index.
|
520 |
|
|
|a Emerging Therapeutic Options for Hepatitis C.
|
590 |
|
|
|a ProQuest Ebook Central
|b Ebook Central Academic Complete
|
650 |
|
0 |
|a Hepatitis C
|x Treatment.
|
650 |
|
0 |
|a Hepatitis C
|x Chemotherapy.
|
650 |
|
0 |
|a Antiviral agents.
|
650 |
1 |
2 |
|a Hepatitis C
|x therapy
|
650 |
1 |
2 |
|a Hepatitis C
|x drug therapy
|
650 |
1 |
2 |
|a Antiviral Agents
|x therapeutic use
|
650 |
|
2 |
|a Antiviral Agents
|
650 |
|
6 |
|a Hépatite C
|x Traitement.
|
650 |
|
6 |
|a Hépatite C
|x Chimiothérapie.
|
650 |
|
6 |
|a Antiviraux.
|
650 |
|
7 |
|a Antiviral agents
|2 fast
|
650 |
|
7 |
|a Hepatitis C
|x Treatment
|2 fast
|
655 |
|
4 |
|a Internet Resources.
|
700 |
1 |
|
|a Omata, Masao.
|
700 |
1 |
|
|a Kanda, Tatsuo.
|
710 |
2 |
|
|a Future Medicine Ltd.
|
758 |
|
|
|i has work:
|a Emerging therapeutic options for hepatitis C (Text)
|1 https://id.oclc.org/worldcat/entity/E39PCGTHRQX9ydGc4HpCyV9CcP
|4 https://id.oclc.org/worldcat/ontology/hasWork
|
776 |
0 |
8 |
|i Print version:
|z 9781780842721
|
856 |
4 |
0 |
|u https://ebookcentral.uam.elogim.com/lib/uam-ebooks/detail.action?docID=1179645
|z Texto completo
|
938 |
|
|
|a EBL - Ebook Library
|b EBLB
|n EBL1179645
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 10899202
|
994 |
|
|
|a 92
|b IZTAP
|